NCT03619122 is a NA clinical trial of Second Examination in Colon Adenoma, sponsored by Ningbo No. 1 Hospital.

Who is sponsoring NCT03619122?

NCT03619122 is sponsored by Ningbo No. 1 Hospital.

What drugs are being tested in NCT03619122?

Interventions in NCT03619122: Second Examination.

What condition does NCT03619122 study?

NCT03619122 studies Colon Adenoma.

Is NCT03619122 still recruiting?

NCT03619122 is currently completed. Last updated 12 July 2019.

Last reviewed 2019-07-12 · How we verify

NCT03619122

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Second Forward View Examination of Proximal Colon on Adenoma Detection Rate

Completed NA Last updated 12 July 2019

What this trial tests

NA trial testing Second Examination in Colon Adenoma in 392 participants. Completed in 30 June 2019.

Timeline

1 September 2018

Primary endpoint
31 May 2019

30 June 2019

Quick facts

Lead sponsor	Ningbo No. 1 Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	screening
Enrollment	392
Start date	1 September 2018
Primary completion	31 May 2019
Estimated completion	30 June 2019
Sites	1 location across China

Drugs / interventions tested

Second Examination

Conditions studied

Colon Adenoma — all drugs for Colon Adenoma →

Sponsor

Ningbo No. 1 Hospital

Who can join

Adults 18 to 75, any sex, with Colon Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial is being conducted to assess whether second forward view examination of proximal colon could increase adenoma detection rate of right colon.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Impact of second forward-view examination on adenoma detection rate during unsedated colonoscopy: a randomized controlled trial.
Shan K, Lu H, Zhang Z, Xie J, et al · · 2021 · cited 8× · PMID 33971824 · DOI 10.1186/s12876-021-01783-9
Impact of Second Forward-view Examination of the Right side of the Colon on Polyp and Adenoma Detection during Colonoscopy: A Randomized Controlled Trial
Shan K, Lu H, Zhang Z, Xie J, et al · · 2021 · DOI 10.21203/rs.3.rs-141084/v1

Verify or expand the search:

Other recruiting trials for Colon Adenoma

Currently open trials in the same condition.

NCT06550908 — Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images · NA · recruiting
NCT07450612 — Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection · recruiting
NCT05041478 — Cold Snare Endoscopic Mucosal Resection (EMR) vs Cold EMR With Margin Snare Tip Soft Coagulation (STSC) · NA · recruiting
NCT05355363 — Risk of Metachronous Findings After Detection of Serrated Lesions and High-grade Dysplasia With Surveillance Delay · NA · recruiting
NCT05402696 — St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C) · recruiting

Other Ningbo No. 1 Hospital trials

Trials by the same sponsor.

NCT07181759 — Clinical Trial of VISOR vs fURS for Upper Urinary Tract Stone · NA · not yet recruiting
NCT07001865 — Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia · enrolling by invitation
NCT06984510 — Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population · recruiting
NCT06905795 — Screening and Intervention of MASLD in Children · NA · active not recruiting
NCT06987760 — Comparing Different Diameter fURSs With Similar RESDs for the Treatment of Upper Urinary Tract Stones · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03619122 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ningbo No. 1 Hospital
Last refreshed: 12 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03619122.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing